TERADYNE, INC·4

Jul 2, 1:11 PM ET

JOHNSON MERCEDES 4

4 · TERADYNE, INC · Filed Jul 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Teradyne Director Mercedes Johnson Sells 167 Shares

What Happened
Mercedes Johnson, a director of Teradyne, Inc. (TER), sold 167 shares in an open-market sale on July 1, 2026 at $460.00 per share, for a total proceeds of $76,820. This was a sale (not a purchase or award).

Key Details

  • Transaction date and price: 2026-07-01 — 167 shares @ $460.00 each = $76,820.
  • Transaction type: Sale (code S). Reported as an open-market or private sale.
  • Filing date: Form 4 filed 2026-07-02 (timely; Form 4 generally due within two business days).
  • Shares owned after transaction: Not disclosed on this filing.
  • Footnotes of note:
    • F1: The shares were sold pursuant to a sales plan adopted by the reporting person on March 4, 2026 intended to comply with SEC Rule 10b5-1 (a prearranged trading plan).
    • F2: Shares are held by The Mercedes Johnson Trust UAD 07/23/04; Mercedes Johnson is the trustee and sole beneficiary.

Context
Sales executed under a Rule 10b5-1 plan are prearranged and often routine, which can limit their interpretive value about an insider’s current view of the company. This filing reports a director-level sale (not an executive option exercise or a gift).

Insider Transaction Report

Form 4
Period: 2026-07-01
Transactions
  • Sale

    Common Stock

    [F1]
    2026-07-01$460.00/sh167$76,8206,697 total
Holdings
  • Common Stock

    [F2]
    (indirect: By Trust)
    1,876
Footnotes (2)
  • [F1]The shares were sold pursuant to a sales plan adopted by the Reporting Person on March 4, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  • [F2]Shares held by The Mercedes Johnson Trust UAD 07/23/04 (the "Trust"), of which the Reporting Person is the trustee and sole beneficiary.
Signature
/s/ Ryan E. Driscoll, Attorney-in-Fact|2026-07-02

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT